Literature DB >> 9046351

Effects of log P and phenyl ring conformation on the binding of 5-phenylhydantoins to the voltage-dependent sodium channel.

M L Brown1, G B Brown, W J Brouillette.   

Abstract

Binding to the neuronal voltage-dependent sodium channel (NVSC) was evaluated for 12 5-phenylhydantoins which systematically varied either log P and/or 5-phenyl ring orientation. The linear correlation of log P with in vitro sodium channel binding activity (log IC50) for hydantoins 1-12 and diphenylhydantoin (DPH) (r2 = 0.638) suggested that simple partitioning into the lipid phase is important but not sufficient to account for the effects of hydantoins on the NVSC. Comparisons among different hydantoins with the same log P but different low-energy phenyl ring orientations revealed that, in addition to log P, the correct 5-phenyl orientation is important for efficient binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046351     DOI: 10.1021/jm960692v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.

Authors:  Gregory M Lipkind; Harry A Fozzard
Journal:  Mol Pharmacol       Date:  2010-07-19       Impact factor: 4.436

2.  Topochemical models for the prediction of voltage-gated sodium channel binding activity of hydantoins and related non-hydantoins.

Authors:  Meenal Gupta; Anil Kumar Madan
Journal:  J Mol Model       Date:  2006-09-07       Impact factor: 1.810

3.  A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile.

Authors:  Paul W Lenkowski; Timothy W Batts; Misty D Smith; Seong-Hoon Ko; Paulianda J Jones; Catherine H Taylor; Ashley K McCusker; Gary C Davis; Hali A Hartmann; H Steve White; Milton L Brown; Manoj K Patel
Journal:  Neuropharmacology       Date:  2006-12-14       Impact factor: 5.250

Review 4.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.

Authors:  Annamaria De Luca; Sophie Talon; Michela De Bellis; Jean-François Desaphy; Carlo Franchini; Giovanni Lentini; Alessia Catalano; Filomena Corbo; Vincenzo Tortorella; Diana Conte-Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-25       Impact factor: 3.000

6.  Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore.

Authors:  Yuesheng Wang; Paulianda J Jones; Timothy W Batts; Victoria Landry; Manoj K Patel; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2008-10-17       Impact factor: 3.641

7.  Comparative molecular field analysis and synthetic validation of a hydroxyamide-propofol binding and functional block of neuronal voltage-dependent sodium channels.

Authors:  Milton L Brown; Hilary A Eidam; Mikell Paige; Paulianda J Jones; Manoj K Patel
Journal:  Bioorg Med Chem       Date:  2008-12-03       Impact factor: 3.641

8.  Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study.

Authors:  Nora Lenkey; Robert Karoly; Peter Lukacs; E Sylvester Vizi; Morten Sunesen; Laszlo Fodor; Arpad Mike
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

9.  Solvent effects on the structure-property relationship of anticonvulsant hydantoin derivatives: A solvatochromic analysis.

Authors:  Nemanja Trišović; Nataša Valentić; Gordana Ušćumlić
Journal:  Chem Cent J       Date:  2011-10-14       Impact factor: 4.215

10.  Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.

Authors:  Alexandra Lazar; Nora Lenkey; Krisztina Pesti; Laszlo Fodor; Arpad Mike
Journal:  Front Pharmacol       Date:  2015-09-25       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.